Peptide Research Glossary

A compound that binds to a receptor and activates it to produce a biological response.

The fundamental building block of peptides and proteins, consisting of an amino group, a carboxyl group, and a variable side chain.

AMP-activated protein kinase, a cellular energy sensor that activates catabolic pathways and suppresses anabolic processes when energy levels are low.

The biological process of forming new blood vessels from pre-existing vasculature, studied extensively in wound healing and tissue repair research.

A compound that binds to a receptor and blocks its activation without producing an intrinsic response.

A laboratory procedure designed to detect, quantify, or characterize a specific biological substance, activity, or compound property.

Brain-Derived Neurotrophic Factor, a neurotrophin that supports neuronal survival, synaptic plasticity, and cognitive function in preclinical research models.

The fraction of an administered compound that reaches the systemic circulation in active form.

A measurable biological indicator used to assess disease state, compound activity, or physiological change in research models.

A quality document accompanying each research peptide lot that reports purity, identity, molecular weight, and other analytical test results.

The biological process by which cells produce collagen proteins, the primary structural component of connective tissue and extracellular matrix.

The biological mechanism by which copper-binding peptides such as GHK-Cu deliver copper ions to cellular targets to activate wound healing, collagen synthesis, and antioxidant enzymes.

The quantitative relationship between the amount of a compound administered and the magnitude of biological effect observed in a research model.

A research design in which neither the subjects nor the researchers assessing outcomes know which treatment condition each subject received.

The concentration of a compound that produces 50% of the maximum biological response in a defined experimental assay.

The study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, including DNA methylation and histone modification.

The Drug Enforcement Administration scheduling system that classifies controlled substances by their medical use, potential for abuse, and safety profile.

A compound that mimics the action of ghrelin at the GHSR-1a receptor to stimulate growth hormone release and related metabolic effects.

Growth Hormone-Releasing Hormone, the endogenous hypothalamic peptide that stimulates growth hormone secretion from the pituitary gland.

A pharmaceutical manufacturing quality standard requiring validated processes, controlled environments, and extensive documentation for compounds intended for human or clinical use.

Gonadotropin-Releasing Hormone, the master hypothalamic peptide regulating reproductive hormone secretion through the pituitary-gonadal axis.

"Generally Recognized As Safe" — an FDA designation for food substances that qualified experts consider safe under conditions of intended use based on established evidence.

A 191-amino acid polypeptide hormone secreted by the pituitary gland that regulates growth, metabolism, and body composition studied in preclinical endocrinology research.

A compound that stimulates the release of growth hormone from pituitary cells through receptor-mediated mechanisms.

The time required for the concentration of a compound in a biological system to decrease by half.

High-Performance Liquid Chromatography, an analytical separation technique used to verify the purity and identity of research peptide compounds.

The concentration of a compound that inhibits a biological process or receptor by 50% under defined experimental conditions.

Insulin-like Growth Factor 1, a downstream mediator of growth hormone signaling produced primarily in the liver that drives anabolic and growth effects.

Research conducted outside of a living organism, typically in cell culture or isolated tissue systems.

Research conducted within a living organism, providing whole-system pharmacological context for compound evaluation in animal models.

A preclinical research delivery route in which a compound is injected directly into a vein for immediate systemic distribution in animal models.

An FDA regulatory application that must be submitted before a new compound can be studied in human clinical trials in the United States.

The signaling pathway by which kisspeptin peptides activate GPR54 receptors on GnRH neurons to drive reproductive hormone secretion.

The tendency of a compound to dissolve in or associate with lipid-based (fatty) environments rather than aqueous environments.

A freeze-drying process that removes water from a peptide solution under vacuum to produce a stable, dry powder suitable for long-term storage.

The freeze-dried solid form in which research-grade peptides are supplied for storage stability and long-term shelf life.

An analytical technique that measures the mass-to-charge ratio of ionized molecules, used to confirm the molecular weight and identity of research peptide compounds.

A family of G protein-coupled receptors activated by melanocortin peptides, with roles in pigmentation, inflammation, reproductive, and energy homeostasis research.

The collective biological activities of mitochondria including ATP production, reactive oxygen species regulation, calcium handling, and signaling relevant to aging and metabolic research.

The mass of a molecule expressed in daltons (Da) or kilodaltons (kDa), calculated from the sum of atomic masses of all constituent atoms.

Nuclear factor kappa-light-chain-enhancer of activated B cells, a transcription factor family regulating inflammatory and immune gene expression.

An enzyme family that catalyzes the production of nitric oxide from L-arginine, playing a key role in vascular and inflammatory regulation.

A short chain of amino acids linked by peptide bonds, generally defined as fewer than 50 amino acid residues, with diverse biological activities studied across research domains.

The covalent chemical bond formed between the carboxyl group of one amino acid and the amino group of another, linking amino acids into a peptide chain.

The proportion of a peptide preparation that consists of the target compound rather than related impurities, synthesis byproducts, or degradation products.

The chemical process of building peptide chains by sequentially joining amino acids, producing defined sequences for research use.

The study of the biochemical and physiological effects a compound produces in a biological system and the mechanisms underlying those effects.

The study of how a compound moves through a biological system, covering absorption, distribution, metabolism, and excretion.

A research design that includes a control group receiving an inert substance matched in appearance to the treatment compound, enabling isolation of true compound effects.

An experimental system (cell culture, animal model, or ex vivo preparation) used to study compound effects before advancing to human clinical research.

A large biological macromolecule made of folded amino acid chains that performs structural, enzymatic, and signaling functions in living systems.

A research study design in which participants or subjects are randomly assigned to treatment or control conditions to establish causal relationships between compound and outcome.

The non-covalent interaction between a compound and a specific receptor protein that initiates downstream biological signaling.

The process of dissolving a lyophilized peptide powder in an appropriate solvent to prepare a solution for research use.

A quality standard for compounds sold for research purposes, characterized by defined purity specifications and analytical documentation but not meeting pharmaceutical GMP manufacturing standards.

A regulatory designation indicating that a compound is intended solely for laboratory research purposes and is not approved for human consumption or therapeutic use.

The most restrictive DEA controlled substance category, designating compounds with no accepted medical use and high potential for abuse.

A DEA controlled substance category for compounds with accepted medical uses but high abuse potential, requiring strict regulatory controls for research and prescription use.

The cellular process by which an extracellular signal (such as a receptor-binding compound) is converted into an intracellular response through a cascade of molecular events.

A family of NAD+-dependent protein deacylases that regulate gene expression, metabolism, and cellular stress responses relevant to aging biology.

The standard method for producing synthetic research peptides, in which the growing peptide chain is assembled on a solid resin support through iterative amino acid coupling cycles.

A research delivery method in which a compound is injected into the subcutaneous tissue layer beneath the skin in animal models.

A peptide produced by chemical synthesis rather than biological expression, enabling precise sequence control and incorporation of non-natural modifications for research use.

Protective DNA-protein caps at chromosome ends that shorten with each cell division and serve as a marker of cellular replicative age.

A family of small peptides originally isolated from thymus tissue that regulate immune function, cellular migration, and tissue repair.

Vascular Endothelial Growth Factor, a signaling protein that promotes the formation of new blood vessels (angiogenesis) in preclinical research models.

The maximum amount of a compound that can dissolve in water at a given temperature and pH.